BENADRYL ALLERGY OTC
Generic Name and Formulations:
Diphenhydramine HCl 25mg; caps; tabs; dye-free liq-filled softgels.
McNeil Consumer Healthcare
Indications for BENADRYL ALLERGY:
Symptoms of upper respiratory allergies. Rhinorrhea/sneezing due to common cold.
25–50mg every 4–6hrs; max 300mg/day.
<6yrs: individualize. 6–12yrs: 12.5–25mg every 4–6hrs; max 150mg/day.
Neonates. Premature infants. Acute asthma. Concomitant diphenhydramine products (including topicals).
Asthma and lower respiratory disorders. Glaucoma. Hyperthyroidism. Hypertension. Cardiovascular disease. GI or urinary obstruction. Sodium-restricted diet. Children. Pregnancy (Cat.B in 3rd trimester): not recommended. Nursing mothers.
Potentiates CNS depression with alcohol, other CNS depressants. Potentiates anticholinergic effects with MAOIs.
Drowsiness, dizziness, anticholinergic effects, excitability in children.
Caps—24, 48; Tabs—24, 48, 100; Dye-free softgels—24; Allergy Liq—4oz, 8oz; Dye-free Liq—4oz; Inj—contact supplier
Neurology Advisor Articles
- OCD in Duchenne Muscular Dystrophy Features Distinct Phenotype, Associated Symptoms
- History of Migraine Associated With Higher Risk for Cochlear Disorders
- Patent Foramen Ovale Closure for Stroke Prevention: Key Principles for Clinical Practice
- Vagus Nerve Stimulation in Pediatric Epilepsy: Weighing the Risks and Benefits
- A Model for Predicting Quality of Life Improvements After Deep Brain Stimulation
- Some Statins May Be Associated With Cognition, Memory Deficits
- Neuropathic Pain Treatments
- Cannabis for Multiple Sclerosis: Prescriber's Perspective
- New Monoclonal Antibody BAN2401 Reduces Amyloid Plaques, Improves Cognition in Alzheimer's
- Nonpharmacologic Interventions for Alzheimer's Have Greater Impact on Outcomes Than Currently Available Medications
- Population-Based Incidence of Acute Idiopathic Optic Neuritis Estimated
- First-in-Class Therapy Approved for Polyneuropathy Caused by hATTR
- High Anxiety Symptoms Prevalent in Epilepsy, Mesial Temporal Sclerosis
- Advance Care Planning Doesn't Aid Quality of Life
- Variation in Specialty Drug Coverage Across Health Plans